Paper31502016
Editorial: A Novel Monoclonal Antibody-Targeting Angiogenesis by Inhibiting Secreted Frizzled-Related Protein 2.
Lang JE and 2 others. Ann Surg Oncol, 2019. Cited by 1 paper, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Editorial: A Novel Monoclonal Antibody-Targeting Angiogenesis by Inhibiting Secreted Frizzled-Related Protein 2. Papers, record 31502016. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31502016
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Editorial: A Novel Monoclonal Antibody-Targeting Angiogenesis by Inhibiting Secreted Frizzled-Related Protein 2.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| Membrane Proteins | Major topic |
| Neovascularization, Pathologic | Major topic |
| Humans | |
| Secreted Frizzled-Related Proteins |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P30 CA014089 | NCI NIH HHS | United States | P30CA014089 | PubMed and NIH |
| P30CA014089 | NCI NIH HHS | United States | P30CA014089 | PubMed and NIH |
Source NIH RePORTER
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29,508,855 | Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges. | Nat Rev Clin Oncol | 2018 | https://conductscience.org/library/papers/29508855 | PubMed |
| 2 | 12,689,940 | Synergy between tumor immunotherapy and antiangiogenic therapy. | Blood | 2003 | https://conductscience.org/library/papers/12689940 | PubMed |
| 3 | 19,458,075 | Secreted frizzle-related protein 2 stimulates angiogenesis via a calcineurin/NFAT signaling pathway. | Cancer Res | 2009 | https://conductscience.org/library/papers/19458075 | PubMed |
| 4 | 29,434,333 | Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa. | Nat Rev Clin Oncol | 2018 | https://conductscience.org/library/papers/29434333 | PubMed |
| 5 | 20,554,717 | Angiogenesis inhibitors: current strategies and future prospects. | CA Cancer J Clin | 2010 | https://conductscience.org/library/papers/20554717 | PubMed |
| 6 | 28,808,589 | Anti-angiogenic agents for the treatment of solid tumors: Potential pathways, therapy and current strategies - A review. | J Adv Res | 2017 | https://conductscience.org/library/papers/28808589 | PubMed |
| 7 | 21,435,468 | A novel function for programmed death ligand-1 regulation of angiogenesis. | Am J Pathol | 2011 | https://conductscience.org/library/papers/21435468 | PubMed |
| 8 | 19,581,909 | Adverse effects of anticancer agents that target the VEGF pathway. | Nat Rev Clin Oncol | 2009 | https://conductscience.org/library/papers/19581909 | PubMed |
| 9 | 4,938,153 | Tumor angiogenesis: therapeutic implications. | N Engl J Med | 1971 | https://conductscience.org/library/papers/4938153 | PubMed |
| 10 | 24,482,243 | Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions. | Angiogenesis | 2014 | https://conductscience.org/library/papers/24482243 | PubMed |
| 11 | 26,171,757 | Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis. | Genes Chromosomes Cancer | 2015 | https://conductscience.org/library/papers/26171757 | PubMed |
| 12 | 9,990,069 | Synergy between an antiangiogenic integrin alphav antagonist and an antibody-cytokine fusion protein eradicates spontaneous tumor metastases. | Proc Natl Acad Sci U S A | 1999 | https://conductscience.org/library/papers/9990069 | PubMed |
| 13 | 26,905,812 | The fusion protein SS18-SSX1 employs core Wnt pathway transcription factors to induce a partial Wnt signature in synovial sarcoma. | Sci Rep | 2016 | https://conductscience.org/library/papers/26905812 | PubMed |
| 14 | 28,361,267 | Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy? | Angiogenesis | 2017 | https://conductscience.org/library/papers/28361267 | PubMed |
| 15 | 15,637,262 | Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. | Science | 2005 | https://conductscience.org/library/papers/15637262 | PubMed |
| 16 | 25,987,985 | Preclinical mouse models of osteosarcoma. | Bonekey Rep | 2015 | https://conductscience.org/library/papers/25987985 | PubMed |
| 17 | 17,602,073 | Bevacizumab 5 mg/kg can be infused safely over 10 minutes. | J Clin Oncol | 2007 | https://conductscience.org/library/papers/17602073 | PubMed |
| 18 | 7,972,041 | Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene. | Proc Natl Acad Sci U S A | 1994 | https://conductscience.org/library/papers/7972041 | PubMed |
| 19 | 21,941,296 | The parallel lives of angiogenesis and immunosuppression: cancer and other tales. | Nat Rev Immunol | 2011 | https://conductscience.org/library/papers/21941296 | PubMed |
| 20 | 21,575,861 | High-frequency canonical Wnt activation in multiple sarcoma subtypes drives proliferation through a TCF/β-catenin target gene, CDC25A. | Cancer Cell | 2011 | https://conductscience.org/library/papers/21575861 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD274 | 29,126 | PubTator's text mining | https://conductscience.org/library/genes/29126 | NCBI Gene |
| EGF | 1,950 | PubTator's text mining | https://conductscience.org/library/genes/1950 | NCBI Gene |
| KDR | 3,791 | PubTator's text mining | https://conductscience.org/library/genes/3791 | NCBI Gene |
| PDCD1 | 5,133 | PubTator's text mining | https://conductscience.org/library/genes/5133 | NCBI Gene |
| SFRP2 | 6,423 | PubTator's text mining | https://conductscience.org/library/genes/6423 | NCBI Gene |
| VEGFA | 7,422 | PubTator's text mining | https://conductscience.org/library/genes/7422 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31502016
GET https://conductscience.org/api/papers/v1/31502016/references?page=2